ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China SHANGHAI, March 24, 2025 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")… CISION PRNewswireMarch 24, 2025
FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority HONG KONG, March 24, 2025 /PRNewswire/ — FuSure Reinsurance ("FuSure") is pleased to… CISION PRNewswireMarch 24, 2025
Press ReleaseHLB Launches the 'Senyum-Senyum Raya' Campaign with a Raya Song by HLB Ambassador, Alif Satar KUALA LUMPUR, Malaysia, March 24, 2025 /PRNewswire/ — As the Hari Raya Aidilfitri… CISION PRNewswireMarch 24, 2025
Press ReleaseARTERY AT32 MCU Powers Next-Gen Drone Innovation, Advancing Smart Skies and the Low-Altitude Economy TAIPEI, March 24, 2025 /PRNewswire/ — Continuous innovation in drone technology has… CISION PRNewswireMarch 24, 2025
Evolve: The Latest GPU Benchmark Suite Revolutionary tool redefines performance evaluation for the graphics industry BREDA, Netherlands, March… CISION PRNewswireMarch 24, 2025
Press ReleaseRegistration is On! 2025 CWIEME Shanghai – Your Gateway to Innovation & Connections SHANGHAI, March 24, 2025 /PRNewswire/ — 2025 CWIEME Shanghai is proud to… CISION PRNewswireMarch 24, 2025
CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer SUZHOU, China, March 24, 2025 /PRNewswire/ — CStone Pharmaceuticals ("CStone", HKEX: 2616),… CISION PRNewswireMarch 24, 2025
Press ReleaseAsia's First Single Stock Leveraged & Inverse Products to Debut on HKEX HONG KONG, March 24, 2025 /PRNewswire/ — CSOP Asset Management Limited (CSOP), the… CISION PRNewswireMarch 24, 2025
